Journal
NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 20, Issue 3, Pages 317-325Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2499
Keywords
-
Funding
- National Cancer Institute (NCI) [1R01CA138835-01]
- Research Scholar Grant from the American Cancer Society
- Department of Defense Breast Cancer Idea Award
- UPENN-Fox Chase Cancer Center (FCCC)
- NCI [1R01CA132878]
- Mayo Clinic Breast Cancer SPORE NCI [P50CA116201]
Ask authors/readers for more resources
The pathogenic sequelae of BRCA1 mutation in human and mouse cells are mitigated by concomitant deletion of 538P1, which binds histone H4 dimethylated at Lys20 (H4K2Ome2) to promote nonhomologous end joining, suggesting that a balance between BRCA1 and 53BP1 regulates DNA double strand break (DSB) repair mechanism choice. Here we document that acetylation is a key determinant of this balance. TIP60 acetyltransferase deficiency reduced BRCA1 at DSB chromatin with commensurate increases in 53BP1, whereas HDAC inhibition yielded the opposite effect. TIP60-dependent H4 acetylation diminished 53BP1 binding to H4K2Ome2 in part through disruption of a salt bridge between H4K16 and Glu1551 in the 53BP1 Tudor domain. Moreover, TIP60 deficiency impaired homologous recombination and conferred sensitivity to PARP inhibition in a 53BP1-dependent manner. These findings demonstrate that acetylation in cis to H4K2Ome2 regulates relative BRCA1 and 53BP1 DSB chromatin occupancy to direct DNA repair mechanism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available